Phase 3 Study Assessing Lot-to-lot Consistency of RSVPreF3 Vaccine and its Immune Response, Safety, and Reactogenicity When Co-administered with FLU-D-QIV

A single-dose investigational respiratory syncytial virus (RSV) vaccine, RSV prefusion protein F3 (RSVPreF3), was co-administered with a single-dose quadrivalent influenza vaccine (FLU-D-QIV) in a phase 3, randomized, controlled, multicenter study in healthy, non-pregnant women aged 18-49 years. The...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of infectious diseases 2024-07
Hauptverfasser:	Chime, Nnenna, Anspach, Bruno, Jain, Vishal, Laajalahti, Outi, Ollinger, Thierry, Yaplee, Deborah, Kim, Joon Hyung
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!